Paige has been honored as one of the most exciting and innovative digital health startups in New York
Paige has been named to the Digital Health 100, an award led by Digital Health New York (DHNY) that celebrates startups in the New York area leading the charge in driving digital health forward. 2024 marks Paige’s 4th inclusion on the DH100 list, solidifying the company as leaders in healthcare innovation and evolution.
The DH100 coincides with a report that looks at the investment trends, opportunities and challenges in the digital health sector, in which it was noted that “45% of respondents believe that healthcare will see the biggest leap forward in generative AI in 2024, more than any other area.” Paige is dedicated to remaining at the forefront of this transformation by delivering the most advanced, proven pathology AI on the market.
“To earn recognition as true digital health pioneers for the fourth year is a significant achievement, one that speaks to our team’s dedication to transforming the landscape of pathology and cancer care for the better,” said Andy Moye, CEO, Paige. “We are honored to be included alongside so many exciting and powerful companies and are looking forward to driving the continued change the digital health world needs in 2024.”
